OsteoStrong Lawsuit: Injury Claims, Franchise Fraud, and What Consumers Need to Know

Quick Answer: The OsteoStrong lawsuit covers three separate legal tracks — a verified personal injury case that reached an Ohio appellate court (Oliveri v. OsteoStrong, 2021-Ohio-1694), multiple federal franchise fraud disputes, and ongoing consumer false advertising claims tied to unsubstantiated bone density promises. No single class action settlement has been finalized as of June 2026.

What Is the OsteoStrong Lawsuit?

The term “OsteoStrong lawsuit” refers to several distinct legal actions — not one single case. Each action targets a different alleged wrongdoing.

The first is a personal injury negligence claim. A woman suffered a spinal compression fracture at an OsteoStrong facility in Ohio. Her case reached a state appellate court, which ruled against OsteoStrong on both its waiver defense and its assumption of the risk argument.

The second track covers franchise litigation. Multiple franchisees sued OsteoStrong Franchising, LLC in federal court. Their claims involved fraud, misrepresentation in the Franchise Disclosure Document, and breach of contract.

The third track involves consumer protection. Former members allege OsteoStrong made unsubstantiated health claims about bone density improvement. They say those claims induced them to sign long-term, expensive membership contracts.

This article covers all three tracks. Every court name, case citation, and outcome comes from verified public records.

What Is OsteoStrong and How Does It Work? 

OsteoStrong operates membership-based wellness centers across the United States and internationally. Its core service is a process called osteogenic loading — a method that applies brief, high-force mechanical pressure to the skeletal system. The company claims this process stimulates bone growth and improves bone mineral density.

Members typically visit once a week. Each session lasts around 10 to 15 minutes. Participants use four proprietary machines, each targeting a different skeletal region. The equipment operates on a self-regulated hydraulic system.

OsteoStrong’s parent structure is OsteoStrong Franchising, LLC, headquartered in Harris County in the Southern District of Texas. Individual centers are owned and operated by separate franchise holders. That franchise structure becomes legally significant in several of the cases below.

The company has marketed its service to older adults — particularly postmenopausal women — as a non-pharmaceutical alternative for managing osteoporosis and reducing fracture risk. Those specific health outcome promises sit at the center of the consumer fraud allegations.

OsteoStrong Personal Injury Case: Oliveri v. OsteoStrong Case Background

Court: Ohio 11th District Court of Appeals Citation: Oliveri v. OsteoStrong, 2021-Ohio-1694 Decided: May 2021 County of Origin: Lake County, Ohio This is the most thoroughly documented OsteoStrong personal injury case in public court records. Beatrice Oliveri had been diagnosed with osteoporosis. In May 2016, she attended a presentation at a senior center and received an offer for two free OsteoStrong sessions. She consulted her doctor first. Her physician advised her to be careful.

Before her first session at the Lake County facility, Oliveri signed a wellness assessment form. That form included a liability release. She told her instructor she was afraid of the exercises. The instructor responded that the program was “completely different” from standard exercise and that there was “minimal, very minimal risk.” Her first session lasted two to five minutes. She reported no pain.

Her second session had four exercises. After the fourth, the instructor told her to repeat it — and to “do it harder, harder.” She complied. She then felt and heard a pop. The medical diagnosis that followed identified a thoracic compression fracture.

The Negligence Claims

Oliveri sued OsteoStrong in Lake County Common Pleas Court. She alleged the company was negligent on five separate grounds:

• Failure to warn — OsteoStrong did not disclose a known dangerous condition
• Failure to instruct — the staff did not teach her how to use the machine correctly
• Dangerous equipment — the company allowed the use of machines that posed an injury risk
• Inadequate supervision — employees were not trained in the correct technique
• Equipment maintenance — OsteoStrong failed to inspect and maintain its machines

OsteoStrong responded with a motion for summary judgment. It argued two things: Oliveri had waived her right to sue, and she had assumed the risk of injury. The trial court sided with OsteoStrong and upheld the waiver. Oliveri appealed.

How the Waiver Failed OsteoStrong in Court 

The Appellate Decision

The Ohio 11th District Court of Appeals reversed the trial court’s ruling in a unanimous 3-0 decision. Judge Thomas R. Wright authored the opinion. Judges Mary Jane Trapp and Cynthia Westcott Rice concurred.

The key sentence in the waiver read: “I waive my right to pursue legal action against OsteoStrong, its owners, partners, and agents for any physical or mental anguish that I may incur as a result of my participation with the OsteoStrong system.”

Why “Anguish” Is Not “Injury”

The appellate court drew a clear distinction between two words: anguish and injury. The Merriam-Webster Dictionary defines “anguish” as “extreme pain, distress, or anxiety.” That definition sets a high threshold. Damages must reach an extreme level to qualify.

“Injury,” on the other hand, means “hurt, damage, or loss sustained” — a much lower standard. Negligence law does not require a plaintiff’s harm to reach extreme suffering before compensation becomes available.

Judge Wright concluded that OsteoStrong’s waiver — which used “anguish” rather than “injury” — did not clearly waive claims for all negligence-based harm. The waiver was legally insufficient to bar Oliveri’s lawsuit. Ohio law does not require the word “negligence” to appear in a waiver. Even so, a waiver must express a clear and unambiguous intent to release the other party from liability for negligence. This waiver did not.

The Assumption of Risk Defense Also Failed

OsteoStrong also argued that Oliveri assumed the inherent risks of exercise. The court rejected this, too. Ohio’s primary assumption of the risk doctrine applies only to risks that are inherent to the activity itself. The court gave examples of inherent exercise risks: tripping off a treadmill, a weight falling on a foot, and being struck by equipment during normal use.

Oliveri’s injury was different. She was correctly performing an exercise under active verbal instruction from an OsteoStrong employee. Her instructor told her to push harder. That instruction — not any inherent exercise risk — was the proximate context of her injury.

The court found the assumption of the risk doctrine inapplicable. The case was reversed and remanded to the trial court.

What This Ruling Means

This decision is significant for anyone who signed a waiver at a fitness facility. Courts do not automatically enforce liability releases. The language must clearly and specifically address negligence. Vague terms — even terms that sound serious, like “anguish” — may not hold up under judicial scrutiny.

OsteoStrong Franchise Lawsuits: Three Federal Cases 

OsteoStrong’s franchise structure generated its own set of federal court disputes. Franchisees across multiple states raised overlapping claims about fraud, FDD omissions, and contract enforcement.

Case 1: Simpson et al. v. OsteoStrong Franchising, LLC

Court: U.S. District Court, Southern District of Texas, Case No.4:19-CV-02334 Key Ruling Dates: November 2021; September 2025 (2025 U.S. Dist. LEXIS 187471) Sean and Charla Simpson became OsteoStrong franchisees in June 2013. They signed three franchise agreements over four years — in June 2013, November 2015, and December 2017 — to develop and operate locations in New Mexico and Colorado. OsteoStrong terminated those agreements in April 2018. The grounds for termination were the Simpsons’ failure to meet their contractual development deadlines.

The Simpsons then filed suit. Their claims covered common law fraud, fraud by non-disclosure, fraudulent inducement, negligent misrepresentation, breach of contract, quantum meruit, unjust enrichment, and defamation.

Their fraud argument rested on two specific allegations:

1. OsteoStrong failed to disclose a company executive’s bankruptcy history and felony conviction in the Franchise Disclosure Document — a violation they characterized as a breach of FTC Franchise Rule disclosure requirements.
2. OsteoStrong misrepresented the regional development training and support it would provide to franchisees.

The Southern District of Texas granted partial summary judgment to OsteoStrong in November 2021. The court found that general releases in the 2015 and 2017 development agreements were valid and enforceable. Those releases barred most of the Simpsons’ affirmative claims. The court also held that the individual franchisee owners had acted as agents for their corporate entities — a finding that bound the companies to the same releases.

A September 2025 ruling addressed the remaining claims. The court continued to favor OsteoStrong on the enforceability of its contractual releases.

Case 2: Baird et al. v. OsteoStrong Franchising, LLC

Court: U.S. District Court, Eastern District of California Citation: 2022 WL 705883 (E.D. Cal. Mar. 9, 2022)

A separate group of franchisees filed suit in the Eastern District of California. Their allegations included:

• Material omissions from OsteoStrong’s Franchise Disclosure Document
• Misrepresentation of the company’s intellectual property rights
• Concealment of prior bankruptcies and lawsuits in the FDD
• Exposure of franchisees to regulatory liability because OsteoStrong marketed its BioDensity equipment as capable of diagnosing or treating medical conditions

OsteoStrong’s franchise agreements contained a forum selection clause. That clause required disputes to be litigated in Harris County, Texas. The court transferred the non-California plaintiffs to the Southern District of Texas on that basis.

The case is a useful example of how forum selection clauses in franchise agreements can move multi-state disputes into a single jurisdiction — typically one more favorable to the franchisor.

Case 3: OsteoStrong Franchising, LLC v. Richter

Court: U.S. District Court, District of New Mexico Case No.: 1:18-cv-1184-KWR-JFR

OsteoStrong initiated this case. It sued former New Mexico franchisees, alleging they had used OsteoStrong’s confidential proprietary information after departing the franchise system to open a competing business called DancingBones.

The district court found OsteoStrong’s trade secret claims inadequately supported. The company’s own representative could not substantiate what specific trade secrets had been misappropriated. The court’s findings reflected a broader issue: OsteoStrong struggled to identify the precise boundaries of the proprietary information it claimed to own.

A Note on the California Preliminary Injunction

In a related California proceeding, the Simpsons sought a preliminary injunction against OsteoStrong. The court denied it. The court found the Simpsons had not demonstrated imminent, irreparable harm. The court also cited OsteoStrong’s representation that it had never received an FDA complaint during its corporate existence. That point did not resolve the underlying fraud claims — it only addressed the injunction standard.

Consumer Fraud and False Advertising Claims 

The personal injury and franchise tracks both involve specific, documented parties. The consumer fraud track is broader. It involves former members across multiple states who allege OsteoStrong’s marketing misled them into paying for services that did not deliver the promised health outcomes.

The Core Allegation

Former members allege that OsteoStrong made specific, measurable health-outcome promises during sales presentations. Those promises, they allege, were not backed by reliable, independent scientific evidence — a pattern also seen in cases involving unsubstantiated health benefit claims against supplement companies.

Memberships at OsteoStrong locations have typically ranged from $150 to $400 per month. Many contracts required a minimum commitment of 12 to 24 months. Members who saw no improvement in DEXA scan results have reported that OsteoStrong made it difficult to cancel contracts or obtain refunds.

The Machine Injury Claims

A lawsuit filed in California in 2023 added a physical injury dimension to the consumer track. It is alleged that OsteoStrong’s machines caused harm, including stress fractures, bone bruises, and muscle tears. These are injuries the company has denied.

The Florida Pyramid Scheme Allegation

A separate Florida lawsuit filed in 2022 raised an entirely different theory. It characterized OsteoStrong’s business model as a pyramid scheme. The complaint alleged that OsteoStrong coaches recruited new customers and earned sales commissions — without any mandatory medical training requirement. OsteoStrong denied this characterization as well.

Media Scrutiny

In 2022, the Wall Street Journal published an investigation that questioned the efficacy of OsteoStrong’s machines and scrutinized the company’s marketing practices. That reporting drew additional attention to the gap between OsteoStrong’s advertised outcomes and the available independent scientific evidence.

The Science Behind OsteoStrong’s Bone Density Claims 

The scientific dispute is an important context for evaluating the consumer fraud claims. OsteoStrong has cited internal studies and a selection of published papers to support its osteogenic loading protocol. The concept of osteogenic loading — applying force to stimulate bone remodeling — does have a basis in bone physiology research.

The dispute is over whether OsteoStrong’s specific machines deliver the outcomes the company advertised. Independent researchers and orthopedic specialists have raised concerns on several points:

• The studies OsteoStrong relies on tend to have small sample sizes
• Much of the supporting research is industry-funded, not independently conducted
• There are no large-scale, peer-reviewed, randomized controlled trials validating the company’s specific clinical claims
• Long-term fracture prevention data are limited and, in some cases, inconsistent

These are not minor technical objections. They go to whether OsteoStrong had a scientific basis for the specific health outcome promises it made to consumers — the legal heart of the false advertising claims.

FTC Standards and Regulatory Exposure  

The Federal Trade Commission requires that health benefit advertising claims be substantiated by competent and reliable scientific evidence before a company makes those claims to consumers. For services marketed as treatments or preventives for medical conditions — such as osteoporosis, bone density loss, or fracture risk — the FTC’s substantiation standard is demanding. Claims must be supported by evidence at a level appropriate to the nature of the claim. Clinical-level claims require clinical-level evidence.

The Baird franchise lawsuit made a directly related allegation. Plaintiffs alleged OsteoStrong marketed its BioDensity equipment as capable of diagnosing, curing, mitigating, treating, or preventing medical diseases. If accurate, that marketing language could implicate FDA medical device classification standards — not just FTC advertising rules.

Consumer advocates have submitted formal complaints to the FTC about OsteoStrong. No public enforcement action had been announced as of June 2026. However, FTC scrutiny of wellness franchise health advertising has intensified broadly in recent years. OsteoStrong’s marketing sits in a category that federal regulators actively monitor. Federal scrutiny of wellness franchise health advertising has intensified broadly in recent years. OsteoStrong’s marketing sits in an active regulatory monitoring category — similar to consumer protection claims over fitness and wellness product marketing that have targeted energy drink brands in 2026.

Key Legal Takeaways for Consumers  

A signed waiver is not the end of a legal claim. The Oliveri decision confirms that liability releases must use clear, specific language to bar negligence suits. Courts read ambiguous waivers against the party seeking to enforce them. Consumers who suffered injuries at OsteoStrong and assumed their signed waiver eliminated their rights should consult an attorney before accepting that conclusion.

Instructor conduct at the moment of injury matters. The Oliveri court rejected the assumption of the risk defense precisely because an OsteoStrong employee directed the plaintiff’s movement and encouraged her to push harder at the moment of injury. Active staff instruction — including verbal encouragement — can shift liability.

Franchise releases are powerful but not unlimited. The Simpson litigation shows that contractual releases in development agreements can bar most franchisee claims. However, franchisee claims based on affirmative defenses were not fully barred, and the litigation continued through 2025.

Consumer fraud claims operate on a separate legal standard. Paying members who were misled by health outcome promises did not sign the same broad releases as franchisees. Their claims under state consumer protection statutes — which typically require only proof of a misleading material statement and resulting financial harm — remain on an open legal track.

Documentation strengthens every category of claim. Consumers who want to preserve potential claims should keep membership contracts, payment records, written marketing materials, and any bone density or DEXA scan results they obtained during or after OsteoStrong membership.

Verified Case Reference Table 

FAQs

What is the controversy with OsteoStrong?

The controversy centers on lawsuits, advertising claims, and scientific evidence. OsteoStrong has faced personal injury, franchise fraud, and consumer protection lawsuits. Critics also argue that available research does not support some of the company’s marketing claims regarding bone density and osteoporosis outcomes.

Is OsteoStrong being sued?

Yes. OsteoStrong and related entities have been involved in several lawsuits, including personal injury claims, franchise disputes, and consumer protection cases. Some litigation has remained active through 2025.

Does OsteoStrong reverse osteoporosis?

There is currently no independent, peer-reviewed evidence proving that OsteoStrong reverses osteoporosis. Existing studies have produced mixed results, and several independent reviews have concluded that evidence supporting significant improvements in bone density remains limited.

How much does OsteoStrong cost per month?

Monthly membership fees generally range from about $100 to $450, depending on the location, membership package, and additional services offered. Some centers also charge enrollment or startup fees.

Written by

Sadia Parveen

Sadia Parveen is a content writer at ClassAction24.com who creates informational articles on class action lawsuits, consumer protection matters, and legal developments. Her work focuses on researching publicly available information and presenting it in a clear and neutral format for general readers. She does not provide legal advice or professional legal services.

EmailLinkedInFacebook